BILLERICA, Mass. – Insulet, a provider of tubeless insulin pumps featuring the Omnipod insulin management system, has received clearance from the U.S. Food and Drug Administration for its Omnipod DASH insulin management system. “Omnipod DASH embodies what users on multiple daily injections have been asking for in a diabetes management system,” said Patrick Sullivan, chairman and CEO, in a statement. “Our No. 1 priority is to continue to minimize the daily strain on those impacted by diabetes and we are confident that this system, and eliminating the system’s upfront cost, do just that.” The Omnipod DASH system features Bluetooth wireless technology for connectivity between the color touch-screen personal diabetes manager and tubeless waterproof pump, and is optimized for use with the CONTOUR NEXT ONE blood glucose meter, as well as the Omnipod DISPLAY and Omnipod VIEW apps.
You are here: / / FDA clears Omnipod insulin management system